Project Description
Empagliflozin
Mechanism of action:
Sodium glucose co-transporter-2 inhibitor (SGLT-2).
Therapeutic Indications:
Type 2 diabetes
Chemical Name:
(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol.
Details
Molecular Weight:
450.9 g/mol
Molecular Formula:
C23H27ClO7
CAS No:
864070-44-0
Product Form
Powder
API Name
Empagliflozin